More Medicines for Tuberculosis (MM4TB) Switzerland
Research
Date range: 1 July 2021 - 30 June 2022
Research collaboration: More Medicines for Tuberculosis (MM4TB) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Relationships
Partner Institutions
More Medicines for Tuberculosis (MM4TB) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- A.N. Bach Institute of Biochemistry, RAS
- Alere Technologies GmbH
- AstraZeneca India
- Cellworks Group
- Collaborative Drug Discovery - CDD VAULT
- Comenius University in Bratislava (UK)
- Indian Institute of Science (IISc)
- Institut Pasteur de Lille (Pasteur-Lille)
- John Innes Centre (JIC)
- National Institute for Health and Medical Research (INSERM)
- Pasteur Institute
- Queen Mary University of London (QMUL)
- Sanofi
- Swiss Federal Institute of Technology Lausanne (EPFL)
- Swiss Federal Institute of Technology Zurich (ETH Zurich)
- University of Cape Town (UCT)
- University of Eastern Piedmont "Amedeo Avogadro" (UNIPMN)
- University of Pavia (UNIPV)
- University of Zaragoza (Unizar)
- University of the Basque Country (UPV/EHU)
- Uppsala University (UU)
- Vichem Chemie Research Ltd.